Skip to main content
SpringerLink
Log in

Large increase in US Medicare Part D spending contributed by oncology

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Ziakas PD, et al. Medicare Part D Spending on Drugs Prescribed by Oncologists: Temporal Trends and Regional Variation. JCO Oncology Practice : OP2000165, 19 Aug 2020

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Large increase in US Medicare Part D spending contributed by oncology. PharmacoEcon Outcomes News 861, 25 (2020). https://doi.org/10.1007/s40274-020-7107-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7107-8

Search

Navigation